128 related articles for article (PubMed ID: 27900016)
1. Expression of aldehyde dehydrogenase family 1 member A1 and high mobility group box 1 in oropharyngeal squamous cell carcinoma in association with survival time.
Qian X; Coordes A; Kaufmann AM; Albers AE
Oncol Lett; 2016 Nov; 12(5):3429-3434. PubMed ID: 27900016
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1).
Szafarowski T; Sierdziński J; Ludwig N; Głuszko A; Filipowska A; Szczepański MJ
Eur J Pharmacol; 2020 Jan; 867():172837. PubMed ID: 31811857
[TBL] [Abstract][Full Text] [Related]
3. Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification.
Leinung M; Ernst B; Döring C; Wagenblast J; Tahtali A; Diensthuber M; Stöver T; Geissler C
Oncol Lett; 2015 Oct; 10(4):2289-2294. PubMed ID: 26622836
[TBL] [Abstract][Full Text] [Related]
4. Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck.
Visus C; Ito D; Amoscato A; Maciejewska-Franczak M; Abdelsalem A; Dhir R; Shin DM; Donnenberg VS; Whiteside TL; DeLeo AB
Cancer Res; 2007 Nov; 67(21):10538-45. PubMed ID: 17974998
[TBL] [Abstract][Full Text] [Related]
5. Expression of aldehyde dehydrogenase 1A1 in oral squamous cell carcinoma and its correlation with clinicopathological parameters.
Gupta V; Maurya MK; Agarwal P; Kumar M; Sagar M; Raghuvanshi S; Gupta S
Natl J Maxillofac Surg; 2022; 13(2):208-215. PubMed ID: 36051794
[TBL] [Abstract][Full Text] [Related]
6. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
7. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
Qian X; Wagner S; Ma C; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
Oncol Rep; 2013 May; 29(5):1777-84. PubMed ID: 23483187
[TBL] [Abstract][Full Text] [Related]
8. Stem cell biomarker ALDH1A1 in breast cancer shows an association with prognosis and clinicopathological variables that is highly cut-off dependent.
Sjöström M; Hartman L; Honeth G; Grabau D; Malmström P; Hegardt C; Fernö M; Niméus E
J Clin Pathol; 2015 Dec; 68(12):1012-9. PubMed ID: 26175266
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma.
Roy M; Connor J; Al-Niaimi A; Rose SL; Mahajan A
Hum Pathol; 2018 Mar; 73():1-6. PubMed ID: 28851663
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of stem cell markers ALDH1A1 and OCT4 as potential biomarkers for the early detection of cervical carcinoma.
Tulake W; Yuemaier R; Sheng L; Ru M; Lidifu D; Abudula A
Oncol Lett; 2018 Nov; 16(5):5525-5534. PubMed ID: 30344706
[TBL] [Abstract][Full Text] [Related]
11. Different Expression of Aldehyde Dehydrogenases 1A1 and 2 in Oral Leukoplakia With Epithelial Dysplasia and in Oral Squamous Cell Carcinoma.
Herrera Costa F; Narana Ribeiro El Achkar V; Costa V; Paladini I; Kowalski LP; Rodarte Carvalho Y; Kaminagakura E
Appl Immunohistochem Mol Morphol; 2019 Aug; 27(7):537-542. PubMed ID: 29189260
[TBL] [Abstract][Full Text] [Related]
12. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
Yang W; Wang Y; Wang W; Chen Z; Bai G
Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
[TBL] [Abstract][Full Text] [Related]
13. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
Li X; Wan L; Geng J; Wu CL; Bai X
J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
[TBL] [Abstract][Full Text] [Related]
15. ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
van der Waals LM; Borel Rinkes IHM; Kranenburg O
PLoS One; 2018; 13(10):e0205536. PubMed ID: 30308036
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of ALDH1A1 in lung, colorectal, and breast cancers: a meta-analysis.
Zhou Y; Wang Y; Ju X; Lan J; Zou H; Li S; Qi Y; Jia W; Hu J; Liang W; Zhang W; Pang L; Li F
Biomark Med; 2015; 9(8):777-90. PubMed ID: 26230297
[TBL] [Abstract][Full Text] [Related]
17. Expression of ALDH1A1 and CD133 is associated with the prognosis and effect of different chemotherapeutic regimens in gastric cancer.
Liu WT; Liu WB; Gao M; Zhang YY; Gu KS
Oncol Lett; 2019 Nov; 18(5):4573-4582. PubMed ID: 31611965
[TBL] [Abstract][Full Text] [Related]
18. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
[TBL] [Abstract][Full Text] [Related]
19. High ALDH1A1 expression indicates a poor prognosis in gastric neuroendocrine carcinoma.
Ye Y; Zhang S; Chen Y; Wang X; Wang P
Pathol Res Pract; 2018 Feb; 214(2):268-272. PubMed ID: 29103772
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.
Tamatani T; Takamaru N; Ohe G; Akita K; Nakagawa T; Miyamoto Y
Oncol Lett; 2018 Jul; 16(1):1133-1140. PubMed ID: 29963189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
